Learning and actioning general principles of cancer cell drug sensitivity
Abstract High-throughput screening of drug sensitivity of cancer cell lines (CCLs) holds the potential to unlock anti-tumor therapies. In this…
Abstract High-throughput screening of drug sensitivity of cancer cell lines (CCLs) holds the potential to unlock anti-tumor therapies. In this…
Abstract Oncodriver genes are usually identified when mutations recur in multiple tumours. Different drivers often converge in the activation or…
Abstract Aberrations in histone post-translational modifications (PTMs), as well as in the histone modifying enzymes (HMEs) that catalyze their deposition…